Campus Event Calendar
Event Entry
What and Who
Bioinformatic Systems for the Improvement of Hepatitis B Therapy
Bastian Beggel
International Max Planck Research School for Computer Science - IMPRS-CS
IMPRS Research Seminar
AG 1, AG 3, AG 4, AG 5, SWS, RG1, MMCI
AG Audience
English
Note: We use this to send email in the morning.
Date, Time and Location
Thursday, 15 October 2009
17:00
60 Minutes
E1 4
024
Saarbrücken
Abstract
Hepatitis B is the most common serious liver infection in the world. Worldwide, about 350 million people are chronic carriers of the hepatitis B virus (HBV). These carriers often need enduring antiviral treatment. My research aims the improvement of treatment possibilities. Therefore, we focus on bioinformatic systems that help us to understand the underlying principles of therapy success and therapy failure. We will build a Web Service that predicts drug resistance w.r.t the available HBV drugs. This system will be based on a statistical model and a set of virological measurements. I will talk about the lesson learned from HIV and the first steps in the development of a model for HBV resistance.
Contact
imprs
225
--email hidden
passcode not visible
logged in users only
Jennifer Gerling, 10/09/2009 14:45
Jennifer Gerling, 10/07/2009 17:08
Jennifer Gerling, 10/07/2009 15:20 -- Created document.
Jennifer Gerling, 10/07/2009 17:08
Jennifer Gerling, 10/07/2009 15:20 -- Created document.